Back to:
Current year's news releases

All news releases
News and information home

Media Memo: Campus Expert Available to Discuss ADHD Drug Label Warnings Campus Expert Available to Discuss ADHD Drug Label Warnings

TO: News/Assignment Editors

FROM: Judy Berthiaume

DATE: March 24, 2006

SUBJECT: Campus Expert Available to Discuss ADHD Drug Label Warnings

Bill Frankenberger, a UW-Eau Claire psychology professor who has done extensive research on stimulant medications used to treat ADHD, is available to talk about recent actions by federal committees regarding calls for strong warnings on the drugs' labels.

This week a federal advisory panel rejected recommendations that drugs used to treat ADHD should include the strongest type of warning about potential cardiovascular and psychiatric risks. Instead, the committee recommended that clearer language be placed on the labels.

The action of the Food and Drug Administration's pediatric advisory committee leaves in doubt if the FDA will require the "black-box" labels on the drugs.

The pediatric advisory committee's action differs from that taken by another committee that had recommended the drugs include stronger warnings. In February, the Drug Safety and Risk Management advisory committee recommended the FDA add the strongest possible warning to some drugs to make doctors, patients and parents aware of the uncertainty regarding the risk they may pose to the cardiovascular system.

The FDA then asked the pediatric panel to study the same issue.

The pediatric advisory committee rejected the Drug Safety and Risk Management recommendation, but did recommend adding clearer information to the labels.

The FDA isn't required to follow the recommendation of its advisory committees, but it typically does.

Experts estimate that nearly 3.3 million Americans age 19 and younger used an ADHD drug last year.

Dr. Frankenberger is available at (715) 836-5020 or frankewr@uwec.edu.

Back to:
Current year's news releases

All news releases
News and information home

 

Excellence. Our Measure. Our Motto. Our Goal.